NCT02072993View on ClinicalTrials.gov

A First Time in Man Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD1979 in Healthy Males

PHASE1TerminatedINTERVENTIONAL
Enrollment

116

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions
Healthy Subjects
Interventions
DRUG

AZD1979

Single dose, oral solution administration

DRUG

Placebo to match

Single dose, oral solution administration

Trial Locations (1)

Unknown

Research Site, Overland Park

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY